Healthcare -
Biotechnology - NASDAQ - US
$ 1.135
-12 %
$ 4.72 M
Market Cap
-0.09
P/E
MBRX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities MBRX - Moleculin Biotech, Inc.
4.65 M
LAST VALUE
-75.05%
2 YEAR CAGR
-17.33%
5 YEAR CAGR
0.00%
10 YEAR CAGR